Global Alzheimer's Platform (GAP) Foundation's GAP-Net Site Optimization Conference Unites 63 Leading Research Sites to Accelerate Alzheimer's Disease Clinical Trials, Feb. 21 - 23
LAS VEGAS, Feb. 22, 2018 /PRNewswire/ -- The brightest minds in Alzheimer's research are meeting in Las Vegas for the Global Alzheimer's Platform Foundation's GAP-Net Site Optimization Conference from Feb 21 - 23. GAP-Net is a first-of-its-kind network of clinical trial sites collaboratively working to streamline clinical research and drug development for Alzheimer's disease. GAP-Net currently has 63 leading academic and private research site partners throughout North America.
The goal of the conference is to provide GAP-Net sites and partners with an idea-sharing platform and the opportunity to discuss challenges, best practices, and strategies. Sites can also share and collaborate on activities at the trans-national, regional and local level. It is the second time this conference will be held after the huge success of the inaugural conference in Orlando, May 2017.
"After the wonderful feedback we received from participants at our first conference, the decision to host another was a question of when, not if," said John Dwyer, President of the Global Alzheimer's Platform Foundation. "The chance to bring North America's most renowned researchers and clinical trial sites together is invaluable in our mission of speeding up the clinical trial process and ultimately finding a cure for Alzheimer's."
Expected conference outcomes include: breaking results of emerging recruiting strategies; proven methods for successful community outreach; shared site start-up best practices and metric alignment; coordination of social and digital media policies; and outreach strategies aimed at both recruiting through primary care physicians and enhancing underserved minority representation in clinical trials.
For more information about the GAP-Net Site Optimization Conference, click here. To get the latest news from the conference as it happens, follow #GAPNetOptCon on Twitter.
Tweet for Media:
The Global Alzheimer's Platform's GAP-Net Site Optimization Conference, led by @dwyerjohnjr, is underway in #LasVegas. GAP-Net is 63 leading #research sites coming together in the fight against #Alzheimers globalalzplatform.org/gap_net_opt_con #GAPNetOptCon
Note to Editors
For interviews with GAP representatives and/or GAP-Net researchers, please contact Brianne Miller at: (650) 575-7727 or brianne@landispr.com.
About Global Alzheimer's Platform Foundation (GAP)
GAP is a patient-centric, non-profit dedicated to speeding the delivery of innovative medicines to those in need by reducing the time and cost of Alzheimer's disease clinical trials. GAP formed a unique and growing network of 59 leading research centers across the U.S. and Canada to help optimize their operations. GAP launched a community-based recruitment model and an online platform designed to accelerate trial recruitment and increase minority representation in research. Based in Washington D.C., GAP was created by UsAgainstAlzheimer's and the Global CEO Initiative (CEOi) in 2015. To learn more about the GAP, please visit globalalzplatform.org.
Media Contact:
Brianne Miller
Landis Communications Inc.
(650) 575-7727
brianne@landispr.com
www.landispr.com
View original content with multimedia:http://www.prnewswire.com/news-releases/global-alzheimers-platform-gap-foundations-gap-net-site-optimization-conference-unites-63-leading-research-sites-to-accelerate-alzheimers-disease-clinical-trials-feb-21---23-300602648.html
SOURCE Global Alzheimer’s Platform Foundation